Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000950170-25-020483·Apogee Therapeutics, Inc.
Schedule 13G ownership disclosure
Apogee Therapeutics Inc
Common Stock, $0.00001 par value per share · CUSIP: 03770N101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RTW Investments, LP
Shares: 2,712,097 · Class: 6%
- Roderick Wong, M.D.
Shares: 2,712,097 · Class: 6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-020483
- Form type
- SCHEDULE 13G
- Filer
- Apogee Therapeutics, Inc.
- CIK
- CIK 1974640
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership